Psyence Biomedical (PBM) Stock Statistics & Valuation Metrics

Psyence Biomedical has a market cap or net worth of $654.81K. The enterprise value is -$7.12M.

Psyence Biomedical has 1,022,177 shares outstanding. The number of shares has decreased by -2.65% in one year.

Psyence Biomedical’s return on equity (ROE) is 0.15 and return on invested capital (ROIC) is -54.49%.

The current PE Ratio of Psyence Biomedical is ―. Psyence Biomedical’s PEG ratio is -0.02.

In the last 12 months, Psyence Biomedical had revenue of 0.00 and earned 1.01M in profits. Earnings per share was 1.78.

In the last 12 months, operating cash flow was -1.05M and capital expenditures -4.00, giving a free cash flow of -1.05M billion.

Psyence Biomedical pays an annual dividend of ―, resulting in a dividend yield of ―

Psyence Biomedical upcoming earnings date is ―, ―.

Psyence Biomedical as a current ratio of 11.04, with Debt / Equity ratio of 0.00%

In the past 12 months, Psyence Biomedical has paid 0.00 in taxes.

Psyence Biomedical EV to EBITDA ratio is -3.66, with an EV/FCF ratio of 1.00.

Psyence Biomedical has $733.00 in cash and marketable securities with $10.45K in debt, giving a net cash position of -$9.71K billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Psyence Biomedical is ―, which is 11.43% higher than the current price. The consensus rating is ―